Biofrontera BFRI
NASDAQ BFRI
$1.48 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Change in Account Payables (2024 - 2025)

Biofrontera (BFRI) posted quarterly Change in Account Payables of -$2.3 million for Q4 2025, down 237.63% year-over-year from $1.7 million in Q4 2024, and down 267.46% quarter-over-quarter from -$630000.0 in Q3 2025.

Biofrontera (BFRI) Change in Account Payables (2024 - 2025) Analysis & Trends

Biofrontera's Change in Account Payables history runs 2 years deep, the most recent figure standing at -$2.3 million for Q4 2025.

  • In Q4 2025, Change in Account Payables fell 237.63% year-over-year to -$2.3 million; the TTM figure through Dec 2025 stood at -$533000.0 (down 50.14% YoY), while the FY2025 annual figure was -$533000.0, down 50.14% from the prior year.
  • Change in Account Payables for Q4 2025 stood at -$2.3 million, down from -$630000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $1.7 million in Q4 2024, with the low at -$2.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Biofrontera 19.06 Mn 14.35 Mn 9.59 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.32 Mn
Dec 31, 2025 -2.32 Mn
Sep 30, 2025 -630,000.00
Sep 30, 2025 -630,000.00
Jun 30, 2025 968,000.00
Jun 30, 2025 968,000.00
Mar 31, 2025 1.44 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 1.68 Mn
Dec 31, 2024 1.68 Mn
Sep 30, 2024 1.40 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 -1.61 Mn
Jun 30, 2024 -1.61 Mn
Mar 31, 2024 -1.83 Mn
Mar 31, 2024 -1.83 Mn